MANČÍKOVÁ, Veronika and Michal ŠMÍDA. Current State of CAR T-Cell Therapy in Chronic Lymphocytic Leukemia. International Journal of Molecular Sciences. Basel: Multidisciplinary Digital Publishing Institute, 2021, vol. 22, No 11, p. 5536-5546. ISSN 1422-0067. Available from: https://dx.doi.org/10.3390/ijms22115536.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Current State of CAR T-Cell Therapy in Chronic Lymphocytic Leukemia
Authors MANČÍKOVÁ, Veronika (703 Slovakia, belonging to the institution) and Michal ŠMÍDA (203 Czech Republic, guarantor, belonging to the institution).
Edition International Journal of Molecular Sciences, Basel, Multidisciplinary Digital Publishing Institute, 2021, 1422-0067.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10608 Biochemistry and molecular biology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 6.208
RIV identification code RIV/00216224:14740/21:00123377
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.3390/ijms22115536
UT WoS 000660178500001
Keywords in English chimeric antigen receptor; immunotherapy; chronic lymphocytic leukemia; CD19
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 18/5/2022 13:27.
Abstract
Chimeric antigen receptor (CAR) T-cell therapy has already achieved remarkable remissions in some difficult-to-treat patients with B-cell malignancies. Although the clinical experience in chronic lymphocytic leukemia (CLL) patients is limited, the proportion of remissions reached in this disease is clearly the lowest from the spectrum of B-cell tumors. In this review, we discuss the antigenic targets exploited in CLL CAR-T therapy, the determinants of favorable responses, as well as the mechanisms of treatment failure specific to this disease.
Links
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
PrintDisplayed: 25/8/2024 16:20